These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7870939)

  • 1. Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
    Byrnes JJ; Miller LG; Greenblatt DJ; Shader RI
    Psychopharmacology (Berl); 1993; 111(1):91-5. PubMed ID: 7870939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
    Galpern WR; Miller LG; Greenblatt DJ; Shader RI
    Br J Pharmacol; 1990 Dec; 101(4):839-42. PubMed ID: 1964820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.
    Koff JM; Pritchard GA; Greenblatt DJ; Miller LG
    Pharmacology; 1997 Nov; 55(5):217-27. PubMed ID: 9399331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of benzodiazepines--V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam.
    Lopez F; Miller LG; Greenblatt DJ; Chesley S; Schatzki A; Shader RI
    Neuropharmacology; 1990 Mar; 29(3):237-41. PubMed ID: 1691458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration.
    Miller LG; Woolverton S; Greenblatt DJ; Lopez F; Roy RB; Shader RI
    Biochem Pharmacol; 1989 Nov; 38(21):3773-7. PubMed ID: 2557030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic benzodiazepine administration: from the patient to the gene.
    Miller LG
    J Clin Pharmacol; 1991 Jun; 31(6):492-5. PubMed ID: 1652596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic benzodiazepine administration. XI. Concurrent administration of PK11195 attenuates lorazepam discontinuation effects.
    Byrnes JJ; Miller LG; Perkins K; Greenblatt DJ; Shader RI
    Neuropsychopharmacology; 1993 May; 8(3):267-73. PubMed ID: 8389555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chronic lorazepam administration in aging mice.
    Fahey JM; Pritchard GA; Reddi JM; Pratt JS; Grassi JM; Shader RI; Greenblatt DJ
    Brain Res; 2006 Nov; 1118(1):13-24. PubMed ID: 16989785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low tolerance and dependence liabilities of etizolam: molecular, functional, and pharmacological correlates.
    Sanna E; Busonero F; Talani G; Mostallino MC; Mura ML; Pisu MG; Maciocco E; Serra M; Biggio G
    Eur J Pharmacol; 2005 Sep; 519(1-2):31-42. PubMed ID: 16107249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.
    Miller LG; Greenblatt DJ; Roy RB; Summer WR; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):177-82. PubMed ID: 2455789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine.
    Galpern WR; Miller LG; Greenblatt DJ; Szabo GK; Browne TR; Shader RI
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S99-104. PubMed ID: 1662953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1992 Apr; 261(1):285-9. PubMed ID: 1313872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.
    Zanotti A; Mariot R; Contarino A; Lipartiti M; Giusti P
    Br J Pharmacol; 1996 Feb; 117(4):647-52. PubMed ID: 8646409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice.
    De Sarro G; Chimirri A; McKernan R; Quirk K; Giusti P; De Sarro A
    Pharmacol Biochem Behav; 1997 Sep; 58(1):281-9. PubMed ID: 9264104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and receptor binding changes during chronic lorazepam administration.
    Fahey JM; Pritchard GA; Grassi JM; Pratt JS; Shader RI; Greenblatt DJ
    Pharmacol Biochem Behav; 2001; 69(1-2):1-8. PubMed ID: 11420062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo.
    Kaplan GB; Cotreau MM; Greenblatt DJ
    J Pharm Pharmacol; 1992 Aug; 44(8):700-3. PubMed ID: 1359103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration.
    Kang I; Miller LG
    Br J Pharmacol; 1991 Jun; 103(2):1285-7. PubMed ID: 1653067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.
    Miller LG; Greenblatt DJ; Barnhill JG; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):170-6. PubMed ID: 2839660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice.
    Burke TF; Miller LG; Moerschbaecher JM
    Pharmacol Biochem Behav; 1994 May; 48(1):69-76. PubMed ID: 7913233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
    Vlainić J; Pericić D
    Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.